GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Medical System Holdings Ltd (HKSE:00867) » Definitions » Intrinsic Value: Projected FCF

China Medical System Holdings (HKSE:00867) Intrinsic Value: Projected FCF : HK$19.23 (As of Jun. 05, 2024)


View and export this data going back to 2010. Start your Free Trial

What is China Medical System Holdings Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-06-05), China Medical System Holdings's Intrinsic Value: Projected FCF is HK$19.23. The stock price of China Medical System Holdings is HK$7.21. Therefore, China Medical System Holdings's Price-to-Intrinsic-Value-Projected-FCF of today is 0.4.

The historical rank and industry rank for China Medical System Holdings's Intrinsic Value: Projected FCF or its related term are showing as below:

HKSE:00867' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.37   Med: 1.02   Max: 4.56
Current: 0.37

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of China Medical System Holdings was 4.56. The lowest was 0.37. And the median was 1.02.

HKSE:00867's Price-to-Projected-FCF is ranked better than
96.32% of 598 companies
in the Drug Manufacturers industry
Industry Median: 1.555 vs HKSE:00867: 0.37

China Medical System Holdings Intrinsic Value: Projected FCF Historical Data

The historical data trend for China Medical System Holdings's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Medical System Holdings Intrinsic Value: Projected FCF Chart

China Medical System Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.06 13.10 15.75 18.95 19.23

China Medical System Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.75 - 18.95 - 19.23

Competitive Comparison of China Medical System Holdings's Intrinsic Value: Projected FCF

For the Drug Manufacturers - Specialty & Generic subindustry, China Medical System Holdings's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Medical System Holdings's Price-to-Projected-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Medical System Holdings's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where China Medical System Holdings's Price-to-Projected-FCF falls into.



China Medical System Holdings Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get China Medical System Holdings's Free Cash Flow(6 year avg) = HK$2,590.94.

China Medical System Holdings's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Dec23)*0.8)/Shares Outstanding (Diluted Average)
=(12.95911409947*2590.9441428571+16975.676*0.8)/2451.989
=19.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Medical System Holdings  (HKSE:00867) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

China Medical System Holdings's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=7.21/19.232093444399
=0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Medical System Holdings Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of China Medical System Holdings's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


China Medical System Holdings (HKSE:00867) Business Description

Traded in Other Exchanges
Address
510 King’s Road, Unit 2106, 21st Floor, North Point, Island Place Tower, Hong Kong, HKG
China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others. Geographically, it derives revenue from China.
Executives
Treasure Sea Limited 2101 Beneficial owner
Lam Kong 2201 Interest of corporation controlled by you

China Medical System Holdings (HKSE:00867) Headlines

No Headlines